Vladimir Kakitelashvili, M.D.

Selected Publications

1986 Myasoedov A., Kakitelashvili V. “ Role of renal prostaglandins in the origin of arterial hypertension in the patients with upper urinary tract obstruction”- Literature review- Medical Abstracts Journal, 1987 Sect. XIX- Urology and Nephrology, No. 12, pp. 17-19.

1991 1. Mazo Y., Kakitelashvili V., Darenkov S. et al “Diagnostic significance of renal prostaglandins levels in patients with renal hypertension”- Urologia i Nephrologia, 1991, No.12, pp. 21-24.

2. Methods of evaluation of patients with renovascular hypertension.
Recommendations, Moscow, 1991.

1994 J.-X. Liu, V. Kakitelashvili and J. Mostwin “ Contractile and cytoskeletal proteins changes are associated with abnormal urodynamic parameters in the obstructed guinea pigs” Abstract. J. of Urol., 1994, Vol.151., N 5, p. 446 A

2000 1. V. Kakitelashvili and J. Donovan “ Secondary Mathieu flip-flap 
urethroplasty- a suitable alternative in the treatment of failed hypospadias repair”. South Central Section of the AUA Annual Meeting, Montreal, Quebec, Canada, September 2000. Podium presentation.

2. V. Kakitelashvili and J. Donovan “Experience with one-stage primary 
hypospadias repair”. South Central Section of the AUA Annual Meeting,
Montreal, Quebec, Canada, September 2000. Podium presentation.

2002 1. V. Kakitelashvili, J Thompson and KC Balaji “Laparoscopic vasectomy; A case report and review of literature”. J. of Endourol. Vol.16 (2), March 2002, pp.105-106.

2. S. Zelivianski, Ph.D., M. Spellman, M.D., M. Kellerman, M.D., 
V. Kakitelashvili, M.D., Xia-wei Zhou, M.D., Rodney J. Taylor, M.D.,
Thomas L. Davis, R. Hauke, M.D., Ming-Fong Lin., Ph.D. 
“ MAPK/ERK inhibitor PD 98056 enhances docetaxel-induced apoptosis of human prostate cancer cells”. South Central Section of AUA Annual Meeting, Colorado Springs, CO, October 2002.

2003 1. S. Zelivianski, M. Spellman, M. Kellerman, V. Kakitelashvili, X-W Zhou, E. Lugo, M-S Lee, R. Taylor, T. Davis, R Hauke, M-F Lin

“ ERK inhibitor PD 98059 enhances docetaxel- induced apoptosis of androgen-independent human prostate cancer cells”, Int. J. Cancer 107, 478-485, 2003.